GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharma Mar SA (WBO:PHM) » Definitions » Total Debt per Share

Pharma Mar (WBO:PHM) Total Debt per Share : €2.21 (As of Sep. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Pharma Mar Total Debt per Share?

€2.21 (As of Sep. 2024)

Total Debt per Share is calculated as total debt divided by Shares Outstanding (EOP). Total debt is calculated as Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Pharma Mar's Total Debt Per Share for the quarter that ended in Sep. 2024 was €2.21.

Pharma Mar Total Debt per Share Historical Data

The historical data trend for Pharma Mar's Total Debt per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharma Mar Total Debt per Share Chart

Pharma Mar Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Debt per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.66 3.13 2.74 2.35 2.48

Pharma Mar Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Total Debt per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.45 2.48 2.30 2.25 2.21

Pharma Mar Total Debt per Share Calculation

Pharma Mar's Total Debt Per Share for the fiscal year that ended in Dec. 2023 is calculated as:

Total Debt Per Share=(Long-Term Debt & Capital Lease Obligation+Short-Term Debt & Capital Lease Obligation)/Shares Outstanding (EOP)
=(28.9+14.8)/17.6
=2.48

Pharma Mar's Total Debt Per Share for the quarter that ended in Sep. 2024 is calculated as:

Total Debt Per Share=(Long-Term Debt & Capital Lease Obligation+Short-Term Debt & Capital Lease Obligation)/Shares Outstanding (EOP)
=(27.2+11.2)/17.4
=2.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharma Mar Total Debt per Share Related Terms

Thank you for viewing the detailed overview of Pharma Mar's Total Debt per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharma Mar Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharma Mar SA (WBO:PHM) » Definitions » Total Debt per Share
Comparable Companies
XMAD:ATRY XMAD:ORY XMAD:BST XMAD:VYT XMAD:ROVI VRTX REGN ASX:CSL XKRX:207940 XBRU:UCB ALNY XBRU:ARGX XKRX:068270 BNTX BGNE MRNA SMMT UTHR OCSE:GMAB XKRX:196170
Traded in Other Exchanges
PHMMF:USA PHMe:UK 0RC6:UK PHM:Spain
Address
Avenida de los Reyes, 1, Poligono Industrial La Mina-norte, Colmenar Viejo, Madrid, ESP, 28770
Website
http://www.pharmamar.com
Pharma Mar SA is engaged in the research, development, production, and commercialization of bio-active principles of marine origin for application in oncology. It also produces and market insecticides and air fresheners for household use, household products, wood treatment and decoration products, paints, and similar products. Its operating business segments are Oncology, Diagnostics, Consumer chemicals, and RNAi. The company obtains its revenues from two main areas: biopharmaceuticals and consumer chemicals, but the biopharmaceuticals is the main line of business.